ZBTB16 and metastatic prostate carcinoma: For example, ZBTB16 (also known as PLZF) is a P1 TSG that inhibits prostate cancer tumor growth through its interplay with PTEN and FOXO3a30, and its genetic alterations have been found in metastatic prostate cancer samples31.